The feasibility of 18F-3′-fluoro-3′-deoxy-l-thymidine PET (FLT PET) for detecting
laryngeal cancer was investigated and compared with 18F-FDG PET. Methods: Eleven …

The evaluation of response to radiotherapy in patients with laryngeal cancer is a challenge
because of the difficulty to differentiate between post-therapy changes and recurrent or …

18F-FDG PET has gained acceptance for staging of esophageal cancer. However, FDG is
not tumor specific and false-positive results may occur by accumulation of FDG in benign …

PURPOSE: To evaluate the effectiveness of 2-[fluorine 18] fluoro-2-deoxy-d-glucose (FDG)
positron emission tomography (PET) in the identification of early stage (T1–T2) primary and …

Recent studies suggest a somewhat selective uptake of O-(2-[18F] fluoroethyl)-l-tyrosine
(FET) in cerebral gliomas and in squamous cell carcinoma (SCC) and a good distinction …

Purpose This study aimed to determine whether intravenous contrast-enhanced dual-phase
fluorine-18--fluorodeoxyglucose (18 F-FDG) PET/CT scans provide additional diagnostic …

The aim of the study was to determine the practicability of 18 F-FLT in tumours of the head
and neck area in terms of visualization, a possible correlation between FLT uptake and …

Accelerated tumor cell proliferation is an important mechanism adversely affecting
therapeutic outcome in head and neck cancer. 3′-deoxy-3′-18F-fluorothymidine (18F …

The aim of this study was to evaluate the usefulness of 18 F-FDG PET in the diagnosis and
staging of primary and recurrent malignant head and neck tumours in comparison with …

Fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has evolved to
be an essential imaging modality in the evaluation of laryngeal carcinoma. Although the …